Inovio Pharmaceuticals, Inc. (INO) Institutional Ownership

Ownership Summary

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) showed up in the 13F filings of 3 institutional investors as of March 2024.

• Their combined ownership stood at 0.0% of outstanding shares in March 2024, down from 315.6% in December 2023.
• Their total shares held in INO decreased -92.15% from the prior quarter, while the number of investors in Inovio Pharmaceuticals decreased 98.29% year over year.
• During the quarter, 1 of these 3 funds increased positions in INO, 2 reduced exposure, and 0 held steady.
• Combined, these investors held 10.35K shares in INO for March 2024, down by 121.44K shares quarter on quarter, and down 145.4Mn shares year over year.
• As of March 31, 2024, the biggest holder of Inovio Pharmaceuticals is Green Alpha Advisors, LLC at 65.58K shares, representing 0.28% of shares outstanding.
• The most significant purchases of INO for the quarter ending March 2024 came from Farther Finance Advisors, LLC (20), HM PAYSON & CO (2).
• The largest sales of INO for the quarter ending March 2024 came from Green Alpha Advisors, LLC (6.52K), MJT & Associates Financial Advisory Group, Inc. (325).
• According to Business Quant data, leading holders of INO for March 2024 are Green Alpha Advisors, LLC (65.58K), Mayflower Financial Advisors, LLC (12.56K), SIGNATURE ESTATE & INVESTMENT ADVISORS LLC (11.03K), Activest Wealth Management (1.5K), MJT & Associates Financial Advisory Group, Inc. (325), Root Financial Partners, LLC (208), Farther Finance Advisors, LLC (36), ATWOOD & PALMER INC (18), CoreCap Advisors, LLC (16), Key FInancial Inc (14).